Medicare Enrolled
Dr. Nishith Amin, MD FACC
Interventional Cardiology · Camillus, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Amin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amin
Dr. Nishith Amin is an interventional cardiology specialist in Camillus, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Amin performed 2,527 Medicare services across 2,025 unique beneficiaries.
Between the years covered by Open Payments, Dr. Amin received a total of $3,557 from 34 pharmaceutical and/or device companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 26% volume in NY
$3,557 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,527
Medicare services
Top 26% in NY for interventional cardiology
2,025
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~126 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
905 | $6 | $17 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
632 | $84 | $209 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
324 | $9 | $40 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
90 | $145 | $409 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
71 | $61 | $142 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
52 | $14 | $51 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
45 | $51 | $162 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
44 | $20 | $60 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
41 | $34 | $106 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
41 | $16 | $167 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
41 | $172 | $457 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $118 | $319 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
29 | $14 | $44 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
28 | $12 | $53 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
26 | $19 | $51 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
25 | $11 | $51 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $94 | $266 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
19 | $38 | $76 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
18 | $19 | $189 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $58 | $142 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
12 | $63 | $217 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $132 | $395 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.8% high complexity
5.1% medium
84.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,557
Total received (2018-2024)
Avg $508/year across 7 years
Bottom 38% in NY for interventional cardiology
34
Companies
146
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,557 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$557
2023
$604
2022
$309
2021
$142
2020
$116
2019
$875
2018
$954
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$141
Merck Sharp & Dohme LLC
$97
Amgen Inc.
$82
Novo Nordisk Inc
$78
Inspire Medical Systems, Inc.
$44
Medtronic, Inc.
$42
Lilly USA, LLC
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Lexicon Pharmaceuticals, Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Top 3 companies account for 57.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$445
Cardiovascular Systems Inc.
$395
ABIOMED
$365
Amgen Inc.
$246
AstraZeneca Pharmaceuticals LP
$221
Edwards Lifesciences Corporation
$209
Janssen Pharmaceuticals, Inc
$171
Merck Sharp & Dohme LLC
$169
Lilly USA, LLC
$146
BIOTRONIK INC.
$137
EKOS Corporation
$135
Medtronic, Inc.
$124
Novo Nordisk Inc
$120
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$107
Inari Medical, Inc.
$85
Regeneron Healthcare Solutions, Inc.
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Inspire Medical Systems, Inc.
$44
PFIZER INC.
$39
Lexicon Pharmaceuticals, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$26
Abbott Laboratories
$24
Penumbra, Inc.
$24
Gilead Sciences, Inc.
$23
AbbVie Inc.
$22
Teva Pharmaceuticals USA, Inc.
$18
Cardinal Health 200, LLC
$16
Amarin Pharma Inc.
$16
Medtronic Vascular, Inc.
$14
Collegium Pharmaceutical, Inc.
$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
CeloNova BioSciences, Inc.
$13
Philips Electronics North America Corporation
$12
Boston Scientific Corporation
$11
Top 3 companies account for 33.9% of all-time payments
Associated products mentioned in payments ›
Acticor 7 VR-T DX · Austedo XR · BRILINTA · CAMZYOS · Claria MRI · Corlanor · Coronary Orbital Atherectomy System · EKOSONIC · ELIQUIS · ENTRESTO · EVERA MRI XT DR SURESCAN · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FlowTriever · GENERAL STRUCTURAL HEART · GlideLight · INSPIRE · Impella · Indigo · Inpefa · JARDIANCE · LEQVIO · LINQ II · LifeVest · MOUNJARO · MYCARELINK · Otezla · Ozempic · PERCLOSE PROGLIDE · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Repatha · VERQUVO · VRAYLAR · VYNDAQEL · Vascepa · WINREVAIR · Wegovy · XARELTO · XIFAXAN · XTAMPZA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
8
Per 100K population
1.7
County median income
$74,740
Nearest hospital
ST JOSEPH'S HOSPITAL HEALTH CENTER
8.7 mi
8.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Amin is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Amin experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Amin performed 905 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amin receive payments from pharmaceutical companies?
Yes. Dr. Amin received a total of $3,557 from 34 companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amin's costs compare to other interventional cardiologists in Camillus?
Dr. Amin's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Camillus
Browse interventional cardiologists in Camillus ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in NY
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in NY
Which NY interventional cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology